Stocks Comparison
Balchem vs Innospec: revenue, profit, margins and growth compared
Balchem brought in $1B of revenue in fiscal 2025, Innospec $1.8B in fiscal 2025. Revenue changed by +8.8% at Balchem and -3.7% at Innospec on the year before, so Balchem grew faster. Balchem kept 14.9% of its revenue as net profit, Innospec 6.6%.
Side by side, latest fiscal year
| BCPC | IOSP | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $1B | $1.8B |
| Revenue growth | +8.8% | -3.7% |
| Net income | $154.8M | $116.6M |
| Net margin | 14.9% | 6.6% |
| Free cash flow | n/a | $88M |
| Free cash flow margin | n/a | 4.9% |
| Earnings per share (diluted) | $4.75 | $4.67 |
| Cash | $74.6M | $292.5M |
| Debt | n/a | n/a |
| Price to earnings | 35.4 | 21.1 |
| Market value | $5.4B | $2.4B |
| Dividend yield | 0.57% | 1.73% |
| Rank by revenue in sector | #269 of 451 · Industrials | #231 of 451 · Industrials |
Over the years
BCPC $1BIOSP $1.8B
BCPC $154.8MIOSP $116.6M
BCPC 14.9%IOSP 6.6%
BCPC +8.8%IOSP -3.7%
BCPC $89.5MIOSP $88M
Questions about Balchem and Innospec
Which is bigger by revenue, Balchem or Innospec?
Innospec is bigger by revenue: $1.8B in fiscal 2025, against $1B for Balchem in fiscal 2025.
Which keeps more of its revenue as profit, Balchem or Innospec?
Balchem had a net margin of 14.9% in fiscal 2025; Innospec had 6.6% in fiscal 2025.
Which grew revenue faster, Balchem or Innospec?
In their latest fiscal years revenue changed by +8.8% at Balchem and -3.7% at Innospec.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.